Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol. 2022 Jan;23(1):149-160. doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 11.
Lancet Oncol. 2022.
PMID: 34902335
Free PMC article.
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
Wang H, Yee D, Potter D, Jewett P, Yau C, Beckwith H, Watson A, O'Grady N, Wilson A, Brain S, Pohlmann P; I-SPY 2 Trial Consortium; Blaes A.
Wang H, et al.
Breast Cancer Res Treat. 2024 Apr;204(3):589-597. doi: 10.1007/s10549-023-07214-5. Epub 2024 Jan 12.
Breast Cancer Res Treat. 2024.
PMID: 38216819
Free PMC article.
Item in Clipboard
Cite
Cite